Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 11/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 11/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 8/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 8/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 1.00 |
| ▸ | MAPT | P10636 | 8/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 7/20 | 1.00 |
| ▸ | RECQL | P46063 | 7/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 7/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 1.00 |
| ▸ | XDH | P47989 | 7/20 | 1.00 |
| ▸ | FTO | Q9C0B1 | 7/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 6/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 6/20 | 1.00 |
| ▸ | APP | P05067 | 6/20 | 1.00 |
| ▸ | POLH | Q9Y253 | 6/20 | 1.00 |
| ▸ | POLB | P06746 | 5/20 | 1.00 |
| ▸ | TP53 | P04637 | 5/20 | 1.00 |
| ▸ | IPMK | Q8NFU5 | 5/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quercetin SCHEMBL29351036 | 1.00 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL29353785 | 1.00 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL29723041 | 1.00 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL17629824 | 1.00 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL31507620 | 1.00 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL19723 | 1.00 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL22103 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL6756842 | 0.99 | MEN1 (0.97) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL21585504 | 0.99 | MEN1 (0.97) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL21590136 | 0.99 | MEN1 (0.97) | MEN1KMT2ACYP1A2CYP3A4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104840508-A | Acacia mearnsii leaf extract as well as preparation method and application of acacia mearnsii extract | UNIV NANJING FORESTRY | 2015-08-19 | — | — | CN | claimed |
| CN-118045062-A | Protein-polysaccharide ternary composite nanoparticle loaded with quercetin, and preparation method and application thereof | 合肥工业大学 | 2024-05-17 | — | — | CN | disclosed |
| CN-111836805-B | Pyridine derivatives and their use for the treatment of HIV infection | 吉利德科学公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-115991708-A | HIV inhibitor compounds | 吉利德科学公司 | 2023-04-21 | — | — | CN | disclosed |
| CN-114874220-B | 8-aminobenzene sulfonamide substituted tryptanthrin derivative and preparation and application thereof | 安徽瀚海博兴生物技术有限公司 | 2023-04-21 | — | — | CN | disclosed |
| CN-114874220-A | 8-aminobenzene sulfonamide substituted tryptanthrin derivative and preparation and application thereof | 安徽瀚海博兴生物技术有限公司 | 2022-08-09 | — | — | CN | disclosed |
| CN-113712102-A | Health tea and preparation process thereof | 丛志弘 | 2021-11-30 | — | — | CN | disclosed |
| WO-2021237109-A1 | COMBINATION THERAPY FOR TREATMENT OF VIRAL INFECTIONS | TRAILHEAD BIOSYSTEMS INC. (US) | 2021-11-25 | — | — | WO | disclosed |
| CN-112870184-A | Application of rheum emodin in preparing medicine for treating or improving neurodegenerative diseases | 澳门大学 | 2021-06-01 | — | — | CN | disclosed |
| CN-109999002-A | A kind of preparation method of quercetin nano particle and its preparing the application on anti-breast cancer medicines | 福州大学 | 2019-07-12 | — | — | CN | disclosed |
| US-20090325906-A1 | Methods and compositions for therapeutic treatment | LIMERICK BIOPHARMA, INC. | 2009-12-31 | — | — | US | disclosed |
| WO-2009158031-A2 | METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT | LIMERICK BIOPHARMA, INC. (US) | 2009-12-30 | — | — | WO | disclosed |
| US-20090176810-A1 | COMPOSITION FOR SKIN EXTERNAL APPLICATION CONTAINING GALLOCATECHIN GALLATE FOR MOISTURIZING EFFECT ON THE SKIN | AMOREPACIFIC CORPORATION (KR) | 2009-07-09 | — | — | US | disclosed |
| EP-2068865-A2 | METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT | Limerick BioPharma, Inc. (US) | 2009-06-17 | — | — | EP | disclosed |
| WO-2009018338-A2 | PHOSPHORYLATED PYRONE ANALOGS AND METHODS | LIMERICK BIOPHARMA, INC. (US) | 2009-02-05 | — | — | WO | disclosed |
| WO-2009018326-A2 | SOLUBLE PYRONE ANALOGS METHODS AND COMPOSITIONS | LIMERICK BIOPHARMA, INC. (US) | 2009-02-05 | — | — | WO | disclosed |
| WO-2008083160-A2 | METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT | LIMERICK BIOPHARMA, INC. (US) | 2008-07-10 | — | — | WO | disclosed |
| CN-1883585-A | Pharmaceutical composition for treating atherosclerosis and method for preparing same | JIANGSU KANION PHARMACEUTICAL (CN) | 2006-12-27 | — | — | CN | disclosed |
| EP-1088094-A1 | BIOCATALYTIC PROCESS FOR THE PREPARATION OF 3-0-ACYL-FLAVONOIDS | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2001-04-04 | — | — | EP | disclosed |
| WO-1999066062-A1 | BIOCATALYTIC PROCESS FOR THE PREPARATION OF 3-0-ACYL-FLAVONOIDS | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1999-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090325906-A1 | Methods and compositions for therapeutic treatment | SLC2A1, SLC2A2, SLC2A3 | MEN1 4409/4885KMT2A 4599/4885CYP1A2 3381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.